
Paul Hudson: A Mindset for Miracles
As board chair-elect of the Pharmaceutical Research and Manufacturers of America (PhRMA), Paul Hudson is set to succeed Pfizer CEO Albert Bourla, PhD, in the US trade group’s top seat in 2026. Touching on the annual changeover during a recent wide-ranging sit-down with Pharmaceutical Executive at Sanofi’s Washington, DC, office, the CEO of the French…